Owner Variagenics, Inc. a Delaware corporation

Service Davies Collison Cave

Various Convention priority claimed: 7 November 2000, United States of America, No 76/161241, in respect of REAGENTS FOR SCIENTIFIC, MEDICAL, OR PHARMACEUTICAL RESEARCH USE AND TEST KITS COMPRISED OF SUCH REAGENTS, INCLUDING CHEMICAL TOOLS AND PREPARATIONS FOR CH

Class 1 Chemicals; chemical and biological reagents; cell culture and media; reagents for pharmaceutical research and test kits comprised of such reagents including chemical tools and preparations for chemical cleavage of genetic sequences in a site-specific manner

Class 5 Sera; cell cultures and media for medical purposes; reagents for medical or pharmaceutical use; reagents for medical research use and test kits in this class comprised of such reagents; diagnostic preparation used to identify, in a patient, genetic variations affecting the safety, toxicity, or efficacy of drugs; pharmaceutical preparations and substances

Class 9 Computer hardware and software; computer apparatus and software recorded on magnetic tapes, disks, diskettes, and computers for searching, retrieving, and analyzing databases containing genetic variations in genetic samples observed via mass spectometry or through other analytical methods